Novo Nordisk CEO Lars Jorgensen testifies before US Senate on weight loss drug pricing
epa11622465 Novo Nordisk CEO Lars Jorgensen testifies before the Senate Health, Education, Labor and Pensions Committee hearing on 'Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?' on Capitol Hill in Washington, DC, USA, 24 September 2024. EPA/SHAWN THEW
